期刊文献+

莫西沙星致猝死及机制探讨 被引量:6

原文传递
导出
摘要 目的:由莫西沙星致猝死2例探讨莫西沙星对SD大鼠心肌细胞钾通道KV2.1的影响,明确莫西沙星导致猝死的原因。方法:应用SP法研究莫西沙星对大鼠心肌细胞钾通道KV2.1蛋白表达的变化。结果:莫西沙星严重不良反应可导致猝死;应用莫西沙星的大鼠,心肌细胞钾通道KV2.1蛋白表达明显下调,与对照组比较P<0.01。结论:莫西沙星可以通过影响心肌细胞钾通道KV2.1的下调,引起恶性心律失常,导致猝死。
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2012年第15期1227-1228,共2页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献9

  • 1张晓乐.盐酸莫西沙(拜复乐)[J].临床药物治疗杂志,2003,1(1):55-56. 被引量:7
  • 2Gillian MK,Lesley JS. Moxifloxacin: a review of its use in the management of bacterial infections [J]. Drugs, 2004, 64 (20) : 2347 -2377.
  • 3董晓亮,王海鑫.静脉滴注莫西沙星致谵妄1例[J].中华保健医学杂志,2010,12(1):47-47. 被引量:3
  • 4王琼,蹇在金.莫西沙星致高龄老年人尖端扭转型室性心动过速、室颤1例[J].中国临床保健杂志,2009,12(1):76-76. 被引量:15
  • 5Roden DM, Balser JR, George Jr AL, et al. Cardiac ion channnels[J]. Annu Rev Physiol, 2002,64: 431-475.
  • 6Dixon JE, Mckinnon D. Quantitative analysis of potassium channel mRNA expression in atrial and ventricular muscle of rats[J]. Circ Res, 1994,75 : 252-260.
  • 7Sehultz JH,Volk T,Ehmke H. Heterogeneity of Kv2. 1 mRNA expression and delayed rectifier current in single isolated myo- cytes from rat left ventricle[J]. Circ Res,2001,88 : 483-490.
  • 8Wang W,Hino N, Yamasaki H, et al. Kv2. 1 K + channnels underlie major voltage-gated K + outward current in H9e2 myoblasts[J]. Jpn J Physiol, 200 1, 52 : 507- 514.
  • 9Huang B, Qin D, EI-Sherif N. Spatial alterations of Kv channels expression and K + currents in post-MI remodeled rat heart [J]. Cardiovasc Res, 2001,52 : 246-254.

二级参考文献16

  • 1[1]Stass H, Dalhoff A, Kubitza D. Bay 12~8093: Study on the food the effect after oral administration of 200mg SD to healthy volunteers. ECCMID, 1997, Lausanne: Poster P386.
  • 2[2]Stass H. Pharmacokinetics an elimination of moxifloxacin after oral and intravenous administration in man. J Antimicrob Chemother,1999, 43(Suppl B) 83~90.
  • 3[3]Stass H. Moxifloxacin~ review of clinical pharmacokinetics. Metabolism and Excretion. 6th New Quinolones Symposium 1999, Denver. poster.
  • 4[4]Stass H, Kubitza D. Study to evaluate the interaction between BAY 1208039 and iron ECC, 1998, Hambury: poster.
  • 5[5]Baz MN, Jannetti W, Villanueva C, et al. The efficacy and tolerability of moxifloxacin compared to trovafloxacin in the treatment of acute sinusitis. Todays Ther Trends, 1999, 17(2): 330~319.
  • 6[6]Burke T, Villanueva C, Mariano H, et al. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Clin Ther, 1999, 21(10): 1644~1677.
  • 7[7]Chodosh S, Edabate CA, Haverstock D, et al. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. Respir Med,2000, 94(1): 18~27.
  • 8[8]Wilson R, Kubin R, Ballin I, et al. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbation of chronic bronchitis. J Antimicrob Chemother, 1999, 44(4):501~513.
  • 9[9]Patel T, Pear J, Williams J, et al. Efficacy and safety of ten day moxifloxacin 400mg once daily in the treatment of patients with community~acquired pneumonia. Respir Med, 2000,94(2):97~105.
  • 10[10]Hoffken G, Meyeer HP, Sprenger K, et al. Efficacy and safety of moxifloxacin vs clarithromycin for the treatment of community~acquired pneumonia. J Antimicrob Chermother, 1999, 44(Suppl A): 127.

共引文献21

同被引文献72

  • 1万志龙,刘明亮.莫西沙星的安全性评价[J].国外医药(抗生素分册),2006,27(3):105-109. 被引量:40
  • 2卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆:重庆出版集团重庆出版社,2009:700-701.
  • 3许世伟.莫西沙星致味觉异常1例[J].药物评价,2013,4(2):35.
  • 4Haverkamp W,Kruesmann F,Fritsch A. Update on the cardiac safety of moxifloxacin[J].Curr Drug Saf,2012,(02):149-163.
  • 5Tulkens P M,Arvis P,Kruesmann F. Moxifloxacin safety:an analysis of 14 years of clinical data[J].Drug Development Research,2012,(02):71-100.
  • 6Chuchalin A,Zakharova M,Dokic D. Efficacy and safety of moxifloxacin in acute exacerbatiom of chronic bronchitis:a prospective,multicenter,observational study (AVANTI)[J].BMC Pulmonary Medicine,2013.5.
  • 7Alexandrou A J,Duncan R S,Sullivan A. Mechanism of bERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin[J].British Journal of Pharmacology,2006,(08):905-916.doi:10.1038/sj.bjp.0706678.
  • 8Chen R,Ma W,Yu X. Intravenous moxifloxacin in routine hospital treatment of respiratory tract infections in China:results of a multicenter,noninterventional study[J].IntJGen Med,2011,(04):317-323.
  • 9马坤.莫西沙星致29例不良反应分析[J].中国实用医药,2009,4(3):178-179. 被引量:13
  • 10王琼,蹇在金.莫西沙星致高龄老年人尖端扭转型室性心动过速、室颤1例[J].中国临床保健杂志,2009,12(1):76-76. 被引量:15

引证文献6

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部